Your browser doesn't support javascript.
loading
GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
Ramirez-Lorca, R; Boada, M; Saez, M E; Hernandez, I; Mauleon, A; Rosende-Roca, M; Martinez-Lage, P; Gutierrez, M; Real, L M; Lopez-Arrieta, J; Gayan, J; Antunez, C; Gonzalez-Perez, A; Tarraga, L; Ruiz, A.
Afiliação
  • Ramirez-Lorca R; Department of Structural Genomics, NeoCodex, Sevilla, Spain.
J Nutr Health Aging ; 13(3): 214-9, 2009 Mar.
Article em En | MEDLINE | ID: mdl-19262956
OBJECTIVES: The genetic basis of Alzheimer's disease (AD) is being analyzed in multiple whole genome association studies (WGAS). The GAB2 gene has been proposed as a modifying factor of APOE epsilon 4 allele in a recent case-control WGAS conducted in the US. Given the potential application of these novel results in AD diagnostics, we decided to make an independent replication to examine the GAB2 gene effect in our series. DESIGN: We are conducting a multicenter population-based study of AD in Spain. PARTICIPANTS: We analyzed a total of 1116 Spanish individuals. Specifically, 521 AD patients, 475 controls from the general population and 120 neurologically-normal elderly controls (NNE controls). METHODS: We have genotyped GAB2 (rs2373115 G/T) and APOE rs429358 (SNP112)/rs7412 (SNP158) polymorphisms using real time-PCR technologies. RESULTS: As previously reported in Spain, APOE epsilon 4 allele was strongly associated with AD in our series (OR=2.88 [95% C.I. 2.16- 3.84], p=7.38E-11). Moreover, a large effect for epsilone 4/epsilone 4 genotype was also observed (OR=14.45 [95% C.I., 3.34-125.2], p=1.8E-6). No difference between the general population and the NNE controls series were observed for APOE genotypes (P > 0.61). Next, we explored GAB2 rs2373115 SNP singlelocus association using different genetic models and comparing AD versus controls or NNE controls. No evidence of association with AD was observed for this GAB2 marker (p > 0.17). To evaluate GAB2-APOE genegene interactions, we stratified our series according to APOE genotype and case-control status, in accordance with the original studies. Again, no evidence of genetic association with AD was observed in any strata of GAB2-APOE loci pair (p > 0.34). CONCLUSION: GAB2 rs2373115 marker does not modify the risk of Alzheimer's disease in Spanish APOE epsilon 4 carriers.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Apolipoproteína E4 / Doença de Alzheimer / Heterozigoto Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2009 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Apolipoproteína E4 / Doença de Alzheimer / Heterozigoto Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2009 Tipo de documento: Article